MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra...

BMY posts impressive third-quarter results, with both earnings and sales beating the respective estimates. The company also raises its annual earnings...

ON's third-quarter 2024 performance reflects strong demand for business segment and end-market products.

UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.

MTZ's third-quarter results benefit from strength in the diversified business model and strong bookings of renewable energy projects.

BUD posts solid earnings results in third-quarter 2024. Organic revenues rise 2.1%, led by the ongoing premiumization and higher revenue per...

BUD posts solid earnings results in third-quarter 2024. Organic revenues rise 2.1%, led by the ongoing premiumization and higher revenue per...

MSCI's third-quarter 2024 results benefit from strong growth in recurring subscription revenues.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.